Literature DB >> 32345004

Etiology of bloodstream infections at a population level during 2013-2017 in the Autonomous Community of Valencia, Spain.

L Ruiz-Azcona, M Santibañez, A Gimeno, F J Roig, H Vanaclocha, M P Ventero1, V Boix, J Sánchez-Payá, J Portilla-Sogorb, E Merino, J C Rodríguez.   

Abstract

OBJECTIVE: Bloodstream Infections has become in one of the priorities for the antimicrobial stewardship teams due to their high mortality and morbidity rates. Usually, the first antibiotic treatment for this pathology must be empirical, without microbiology data about the microorganism involved. For this reason, the population studies about the etiology of bacteremia are a key factor to improve the selection of the empirical treatment, because they describe the main microorganisms associated to this pathology in each area, and this data could facilitate the selection of correct antibiotic therapy.
METHODS: This study describes the etiology of bloodstream infections in the Southeast of Spain. The etiology of bacteremia was analysed by a retrospective review of all age-ranged patients from every public hospital in the Autonomous Community of Valencia (approximately 5,000,000 inhabitants) for five years.
RESULTS: A total of 92,097 isolates were obtained, 44.5% of them were coagulase-negative staphylococci. Enterobacteriales was the most prevalent group and an increase in frequency was observed along the time. Streptococcus spp. were the second microorganisms more frequently isolated. Next, the most prevalent were Staphylococcus aureus and Enterococcus spp., both with a stable incidence along the study. Finally, Pseudomonas aeruginosa was the fifth microorganism more frequently solated.
CONCLUSIONS: These data constitute a useful tool that can help in the choice of empirical treatment for bloodstream infections, since the knowledge of local epidemiology is key to prescribe a fast and appropriate antibiotic therapy, aspect capital to improve survival. ©The Author 2020. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Entities:  

Keywords:  Bacteremia; blood cultures; bloodstream infections; etiology

Mesh:

Year:  2020        PMID: 32345004      PMCID: PMC7262391          DOI: 10.37201/req/024.2020

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


INTRODUCTION

Bacteremia diagnosis is one of the priorities of Clinical Microbiology Laboratories due to its high morbility and mortality despite the improvements of antibiotic therapy [1, 2] Owing to this reason, the stewardship groups are choosing this pathology as a prior axis of their performance [3]. Most treatments must be started empirically, with the choice based on the clinical and epidemiological characteristics of the patients, and the local epidemiology. A key point for the manage of this pathology is the availability of empirical therapy guides for each environment, and to achieve this goal it is essential to obtain the etiological data of this pathology in every geographical area [4]. In Autonomous Community of Valencia (AVC, Spain), there is an informatic system to store the etiological data of these processes from all the public hospitals in the region, and so it is possible to perform population studies. The aim of this work was to analyze the etiology of bloodstream infections in Eastern Spain in the period 2013-2017.

MATERIAL AND METHODS

Design. All positive blood cultures from all the public hospitals of the ACV (population: 4,397,476.9) were analyzed from January of 2013 to December of 2017. Source of information. Data were obtained from “RedMIVA”, a microbiological network that connects and unifies the information provided by Microbiological laboratories of Public Hospitals [5]. One isolated was studied per patient. Statistical analyses. We expressed categorical variables as counts (percentage) and continuous variables as mean and standard deviation (SD) or median and InterQuartile Range (IQR), where appropriate. We assessed statistical differences between groups using the chi-square or Fisher’s exact test, for categorical variables. We used the TStudent’s test for the continuous variables. To estimate the rate per 100,000 inhabitants/year, the overall population was obtained from official statistic census. The alpha error was set at 0.05, and all p values were two-tailed. We conducted all statistical analyses using IBM SPSS Statistics version 22.0.

RESULTS

During the period studied (2013-2017) 92,097 clinical isolates were obtained. Global data were analyzed excluding coagulase-negative staphylococci (CNS), because in this study it was not possible to differentiate between culture contamination and true bacteremia caused by this microorganism. The data obtained for CNS were analysed separately. Global rate and prevalence of the main microorganisms and their clusters. The distribution of the main microorganisms classified by year, age, sex and type of hospital is shown in figure 1. The overall incidence rates of bloodstream infections per 100,000 inhabitants caused by bacteria and yeast are shown in table 1, the rates of bacteremia classified by microorganism are shown in table 2.
Figure 1

Distribution of the main microorganisms by year (A), sex (B), age (C) and type of hospital (D).

Table 1

Overall rate of bloodstream infections per 100,000 inhabitantsyear by year (excluding coagulase-negative staphylococci).

Year
20132014201520162017
Number of isolates9,4509,73710,20310,57311,177
ACV total population5,117,1905,129,2665,011,7975,004,1714,974,769
Overall rate of bacteremia184.67189.83203.58211.28224.67
Overall rate of fungemia6.406.166.068.277.67

AVC: Autonomous Community of Valencia.

Table 2

Overall rate of bloodstream infection per 100,000 inhabitants-year due to main Gram-positive and Gram-negative microorganisms by year.

Year
20132014201520162017Average
Gram-positive
Streptococcus spp.27.4525.3027.7928.1730.8527.91
S. aureus17.0417.9519.8519.2420.2618.87
Enterococcus spp.15.917.1317.6117.7218.7917.43
E. faecalis9.9211.6011.5910.9111.8111.17
S. pneumonia4.806.106.486.717.836.38
E. faecium4.804.384.665.555.665.01
Gram-positive bacillli7.626.996.506.377.617.02
Gram-negative
Enterobacterales86.4392.2999.94107.07111.0499.35
E. coli54.0555.0359.1662.7467.0759.61
K. pneumoniae12.1515.2818.0321.0220.2817.35
Pseudomonas spp.11.0411.3611.5910.8911.8711.35
P. aeruginosa6.406.166.968.277.677.09
Anaerobes5.104.404.925.176.535.22
Gram-negative bacilli4.064.364.905.376.475.03
Acinetobacter spp.3.063.332.712.192.472.75
Gram-negative cocci0.500.500.750.771.060.72
Distribution of the main microorganisms by year (A), sex (B), age (C) and type of hospital (D). Overall rate of bloodstream infections per 100,000 inhabitantsyear by year (excluding coagulase-negative staphylococci). AVC: Autonomous Community of Valencia. Overall rate of bloodstream infection per 100,000 inhabitants-year due to main Gram-positive and Gram-negative microorganisms by year. Excluding coagulase-negative staphylococci, Enterobacterales was the most frequently isolated family (49% of the cases) for the period studied and this group showed a trend to increase along the years (p<0.0001). Streptococcus spp. were the second group isolated most often. However, the percentage of this group decreased (p<0.0001). The next most frequently isolated microorganism was Staphylococcus aureus followed by Enterococcus spp. both maintained their prevalence along the period studied. Pseudomonas aeruginosa decreased slightly in the last years (p<0.0001) (figure 1A). When the global data were classified by sex, Enterobacterales were frequently isolated in women (p<0.0001), while S. aureus (p<0.0001), Enterococcus spp. (p<0.0001), and P. aeruginosa (p<0.0001) were more frequently isolated in men (figure 1B). By age, the isolates of Enterobacterales reached 26.8% in people between 0 and 17 years old, versus 58.8% in people older than 85 years and Streptococcus spp. represented the 12.5% in people older than 85 years versus 32.9% in people between 0 and 17 years (p<0.0001) (figure 1C). In hospitals with less than 500 beds, Enterobacterales was the most prevalent family (p <0.0001) (figure 1D). Yeast were more prevalent in hospitals with more than 500 beds, 4.7% against to 2.4% in the smaller hospitals (p<0.0001). Specific distribution of the most clinically relevant microorganisms. The prevalence of Escherichia coli decreased during the studied. This microorganism was more frequently isolated in women (p<0.0001), it was also the most frequently isolated in older patients (p<0.0001). On the other hand, E. coli was also more frequently isolated in hospitals with less than 500 beds than in larger hospitals (p<0.0001). It was more frequently isolated in summer, and spring, and less in winter(p<0.0001). Klebsiella pneumoniae increased from 2013 to 2016, in contrast, in 2017 its prevalence decreased until 17.8%. It was more prevalent in men when compared to women (p<0.0001); in patients between 45 and 64 years old, and in hospitals with more than 500 beds (p<0.0001). It was more frequently isolated in autumn and summer, and less in winter (p<0.0001). P. aeruginosa was more frequently isolated in men than women (p<0.0001); in patients between 18 and 44 years old when compared to patients older than 80 years old (p<0.0001); and in hospitals with more than 500 beds (p<0.0001). It was more frequent in summer than in winter (p<0.0001). When the main Gram-positive microorganisms were analyzed, a decrease of Streptococcus pneumoniae annual prevalence was observed. This microorganism was more frequently isolated in men, in young patients (p<0.0001), and in hospitals with less than 500 beds (p<0.0001). It was more frequently isolated in winter than in summer (p<0.0001). Enterococcus faecalis showed a small decrease along the study (p<0.0001), while Enterococcus faecium isolation rate remained constant. Both microorganisms were more prevalent in men (p<0.0001, both). E. faecalis was more frequently isolated in young patients than in older patients (p<0.0001). On the other side E. faecium was more prevalent in patients between 45 and 64 years. Both were more frequently isolated in hospitals with more than 500 beds (p<0.0001). S. aureus showed minimal changes along the study. Its prevalence was higher in men than women (p<0.0001), in patients younger than 17 years old, and in patients between 45 and 64 years old (p<0.0001). It was more frequent in winter and autumn. These data are shown in table 3.
Table 3

Distribution of the most clinical significance microorganisms by year, sex, age, hospital size and season. Data are expressed in percentage.

Escherichia coliKlebsiella pneumoniaeEnterococcus faecalisStreptococcus pneumoniaeEnterococcus faeciumSalmonella
Year201361.113.711.27.35.51.4
201458.916.412.46.54.61.1
201558.618.011.56.44.60.9
201658.319.510.16.25.30.7
201758.917.810.46.94.91.1
SexMen53.119.513.37.05.91.5
Women66.614.28.46.33.80.7
No stated50.326.76.010.36.01.5
Age0-1737.314.920.715.53.72.4
18-4440.314.68.87.75.61.8
45-6440.620.69.56.16.20.9
65-8445.312.69.95.64.90.9
≥8570.19.58.65.43.30.5
Hospital size<500 beds62.215.410.47.13.81.3
≥500 beds55.419.311.96.26.41.1
SeasonallySpring17.04.13.31.91.40.3
Summer17.35.33.10.61.40.4
Autumn16.65.53.01.81.30.3
Winter14.34.02.83.11.40.1
Distribution of the most clinical significance microorganisms by year, sex, age, hospital size and season. Data are expressed in percentage. Analysis of coagulase-negative staphylococci. During the study period (2013-2017) 40,957 isolates (44.5%) of coagulase-negative staphylococci were obtained. In every year, the percentage of the isolates of these microorganisms remained above 40% but decreasing (p<0.0001). The presence of these microorganisms was age-related, it represented 58.1% between 0-17 years, and 39.4% in older than 85 years (p<0.0001). Besides, it is important to remark that these microorganisms were more prevalent in hospitals with more than 500 beds (48.3% vs 40.5%; p<0.0001) (table 4).
Table 4

Distribution of coagulasenegative staphylococci by year, age and hospital size.

Year
20132014201520162017
46.1%46.3%44.3%43.5%42.4%
Age
0-1718-4445-6465-84≥80
58.150.045.242.239.4
Hospital Size
<500≥500
40.548.3
Distribution of coagulasenegative staphylococci by year, age and hospital size.

DISCUSSION

Bloodstream infections are associated to high mortality and morbidity rates, generating a high cost [6]. However, despite their relevance, there is a low number of population studies that determine the etiology of these processes in wide geographic areas. Studies performed in the 70’s revealed rates of these pathologies between 80 and 189 cases per 100,000 inhabitants/year, and were higher in industrialized countries, in line with population aging and increased healthcare needs [7]. These prevalence rates are lower than the rates found in this study, that shows a rate of bloodstream infections above 200 cases per 100,000 inhabitants/year. A great variability has been observed between geographic areas and calendar year due to population demographic changes, antibiotic prophylaxis, climatic reasons, socioeconomic status or type of study [8, 9]. Classically, it has been considered that the three most common etiologies are E. coli, S. aureus, and S. pneumoniae, which occur at approximate rates of 35, 25 and 10 per 100,000 inhabitants/year, respectively. In our environment, the prevalence rates of these pathogens were 59.61, 18.87 y 6.38 cases per 100,000 inhabitants/ year. S. pneumoniae seems to be displaced by Enterococcus spp. (16.18 cases per 100,000 inhabitants/year) probably due to great number of nosocomial bloodstream infections and the use of anti-pneumococcal vaccine [10, 11]. In our area, Enterobacterales (99.35 cases per 100,000 inhabitants/year) are the microorganisms most frequently involved in this pathology, for that reason it is mandatory to consider the inclusion of drugs active against these pathogens in empiric treatments. It was the most frequently isolated pathogen in women and older patients, probably due to bacteremia with urinary origin, and in small hospitals. K. pneumoniae was more prevalent in hospitals with more than 500 beds, probably because the important number of nosocomial infections caused by this pathogen, and its association to ICU admission [12]. This phenomenon is also characteristic of P. aeruginosa, which has a high mortality rate (29.1%) related to previous comorbidity [13]. These data suggest that empirical treatment for bacteremia in large hospitals should include drugs against these pathogens. On the main Gram-positive microorganism, it was observed a decrease in the prevalence of S. pneumoniae. Despite of this decrease, S. pneumoniae is a pathogen to consider in the empirical treatment because of the invasive pneumococcal disease has a high prevalence in specific collectives as immunosuppressed patients, particularly in patients with HIV infection (331 cases per 100,000 inhabitants/year); in patients with an autologous or allogeneic stem cell transplantation (812 cases per 100,000 inhabitants/year), with a solid organ transplantation (465 per 100,000), and in patients with chronic inflammatory diseases (65 per 100,000), and is associated with high morbidity and mortality [14]. S. pneumoniae were more prevalent in winter, as expected due to the fact that these microorganisms are associated to respiratory pathologies, it has been published that the estimated proportion of pneumococcal pneumonia that is bacteremic is 24.8% [15]. S. pneumoniae was more frequently isolated in young patients due to its high incidence in children, in fact this pathogen is the most prevalent in this age-range (30.5%) [16]. These results show that the empirical treatment for young people in winter with bacteremia derived from pneumonia must be treated with antibiotics against this pathogen. S. aureus were isolated more frequently in hospitals with less than 500 beds, probably because of the changes in nosocomial infection rates related to this pathogen. Our area rate (18.87 cases per 100,000 inhabitants/year) is in line with the range previously published in occidental countries (16-41 cases per 100,000 inhabitants/year). Other geographical areas have communicated an increase of this microorganism, as has occurred in our study [17]. Globally, the data obtained in this study are in line with a population study performed in Denmark. E. coli is also the most prevalent microorganism, followed by S. aureus, K. pneumoniae, E. faecium, E. faecalis, P. aeruginosa and Candida albicans. Besides, results are in agreement with the seasonality of S. pneumoniae, and the association between men patients and bacteremia due to S. aureus, Enterococcus spp. and K. pneumoniae [18]. Our data revealed many isolates of coagulase-negative staphylococci, but a lot of them are associated with patients’ skin microbiome contamination during sample collection. Previous studies, which use the Laboratory-Confirmed Bloodstream Infection (LCBI) criteria, showed that 85% of isolates are contaminants [19]. Despite this limitation we think that there is a high incidence of contaminated blood-cultures in our environment, and for that reason it is mandatory to start formative programs focused on the control of this phenomenon, as our percentage of isolations is higher than the reported in other geographical areas (37.1%) [20, 21]. In the age of antibiotic resistance, this study reveals unknown data to date about the situation of bloodstream infections in our geographical area. These results are useful for designing antibiotic policies in stewardship programs and remark the importance of knowing this type of information in every geographic area. Countries as Denmark have already started strategies in this line by the development of The Danish Collaborative Bacteremia Network (DACOBAN) research database, which is able to report data from 1.7 million residents (32% of the Danish population) [22].
  22 in total

Review 1.  Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremias, reducing contamination, and eliminating false-positive central line-associated bloodstream infections.

Authors:  Robert A Garcia; Eric D Spitzer; Josephine Beaudry; Cindy Beck; Regina Diblasi; Michelle Gilleeny-Blabac; Carol Haugaard; Stacy Heuschneider; Barbara P Kranz; Karen McLean; Katherine L Morales; Susan Owens; Mary E Paciella; Edwin Torregrosa
Journal:  Am J Infect Control       Date:  2015-08-19       Impact factor: 2.918

2.  [The importance of microbiological surveillance networks in monitoring resistant bacteria. RedMIVA].

Authors:  I Muñoz; H Vanaclocha; F González
Journal:  Rev Esp Quimioter       Date:  2007-06       Impact factor: 1.553

3.  Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors.

Authors:  Alejandro Callejas-Díaz; Cristina Fernández-Pérez; Antonio Ramos-Martínez; Elena Múñez-Rubio; Isabel Sánchez-Romero; Juan Antonio Vargas Núñez
Journal:  Med Clin (Barc)       Date:  2018-06-06       Impact factor: 1.725

4.  Setting the baseline to fight Gram-negative bacteraemia: the necessity of epidemiological insights.

Authors:  Stijn Blot
Journal:  Infect Dis (Lond)       Date:  2018-07-25

Review 5.  Bacteremia in children: epidemiology, clinical diagnosis and antibiotic treatment.

Authors:  Sumita Pai; David A Enoch; Sani H Aliyu
Journal:  Expert Rev Anti Infect Ther       Date:  2015-07-04       Impact factor: 5.091

6.  Determination of clinical significance of coagulase-negative staphylococci in blood cultures.

Authors:  Asiye Karakullukçu; Mert Ahmet Kuşkucu; Sevgi Ergin; Gökhan Aygün; Kenan Midilli; Ömer Küçükbasmaci
Journal:  Diagn Microbiol Infect Dis       Date:  2016-12-14       Impact factor: 2.803

7.  Socioeconomic status and risk of intensive care unit admission with sepsis.

Authors:  L Storm; A Schnegelsberg; J Mackenhauer; L W Andersen; M K Jessen; H Kirkegaard
Journal:  Acta Anaesthesiol Scand       Date:  2018-03-22       Impact factor: 2.105

8.  Characteristics of children with microbiologically confirmed invasive bacterial infections in the emergency department.

Authors:  Iker Gangoiti; Juan R Valle; Mercedes Sota; Lorea Martinez-Indart; Javier Benito; Santiago Mintegi
Journal:  Eur J Emerg Med       Date:  2018-08       Impact factor: 2.799

9.  [Economic impact of nosocomial bacteraemia. A comparison of three calculation methods].

Authors:  Marta Riu; Pietro Chiarello; Roser Terradas; Maria Sala; Xavier Castells; Hernando Knobel; Francesc Cots
Journal:  Enferm Infecc Microbiol Clin       Date:  2015-11-10       Impact factor: 1.731

Review 10.  Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review.

Authors:  Hilmir Asgeirsson; Anders Thalme; Ola Weiland
Journal:  Infect Dis (Lond)       Date:  2017-11-06
View more
  4 in total

1.  Incidence of Monomicrobial Staphylococcus aureus Bacteremia: A Population-Based Study in Olmsted County, Minnesota-2006 to 2020.

Authors:  Joya Rita Hindy; Juan A Quintero-Martinez; Brian D Lahr; Raj Palraj; John R Go; Madiha Fida; Omar M Abu Saleh; Verda Arshad; Khawaja M Talha; Daniel C DeSimone; M Rizwan Sohail; Larry M Baddour
Journal:  Open Forum Infect Dis       Date:  2022-04-13       Impact factor: 4.423

Review 2.  Incidence Trends and Epidemiology of Staphylococcus aureus Bacteremia: A Systematic Review of Population-Based Studies.

Authors:  Joya-Rita Hindy; Juan A Quintero-Martinez; Alexander T Lee; Christopher G Scott; Danielle J Gerberi; Maryam Mahmood; Daniel C DeSimone; Larry M Baddour
Journal:  Cureus       Date:  2022-05-29

3.  [Importance of blood cultures results: and special attention for applicants from the Emergency Departament].

Authors:  R Rubio Díaz; I Nieto Rojas; A Julián-Jiménez
Journal:  Rev Esp Quimioter       Date:  2020-09-10       Impact factor: 1.553

4.  Evaluation of Phage Therapy for Pulmonary Infection of Mouse by Liquid Aerosol-Exposure Pseudomonas aeruginosa.

Authors:  Yajun Zhang; Biao Meng; Xiao Wei; Yan Li; Xiaohui Wang; Yan Zheng; Changjun Wang; Lihong Cui; Xiangna Zhao
Journal:  Infect Drug Resist       Date:  2021-10-27       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.